United States Biosimulation Market Report 2017

November 2017 | 102 pages | ID: U9A3A4F98D8WEN
QYResearch

Abstracts

In this report, the United States Biosimulation market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Biosimulation in these regions, from 2012 to 2022 (forecast).

United States Biosimulation market competition by top manufacturers/players, with Biosimulation sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Accelrys
• Certara
• Simulation Plus
• Dassault Systems SA
• Schrodinger
• Advanced Chemistry Development
• Chemical Computing Group
• Entelos Holding Corporation
• Genedata AG
• Physiomics PLC

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Molecular Simulation
• Clinical Trials
• Toxicity Prediction Software
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Scientific Research Institutions
• Government Department
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Biosimulation Market Report 2017

1 BIOSIMULATION OVERVIEW

1.1 Product Overview and Scope of Biosimulation
1.2 Classification of Biosimulation by Product Category
  1.2.1 United States Biosimulation Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Biosimulation Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Molecular Simulation
  1.2.4 Clinical Trials
  1.2.5 Toxicity Prediction Software
  1.2.6 Other
1.3 United States Biosimulation Market by Application/End Users
  1.3.1 United States Biosimulation Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Scientific Research Institutions
  1.3.4 Government Department
  1.3.5 Other
1.4 United States Biosimulation Market by Region
  1.4.1 United States Biosimulation Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Biosimulation Status and Prospect (2012-2022)
  1.4.3 Southwest Biosimulation Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Biosimulation Status and Prospect (2012-2022)
  1.4.5 New England Biosimulation Status and Prospect (2012-2022)
  1.4.6 The South Biosimulation Status and Prospect (2012-2022)
  1.4.7 The Midwest Biosimulation Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Biosimulation (2012-2022)
  1.5.1 United States Biosimulation Sales and Growth Rate (2012-2022)
  1.5.2 United States Biosimulation Revenue and Growth Rate (2012-2022)

2 UNITED STATES BIOSIMULATION MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Biosimulation Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Biosimulation Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Biosimulation Average Price by Players/Suppliers (2012-2017)
2.4 United States Biosimulation Market Competitive Situation and Trends
  2.4.1 United States Biosimulation Market Concentration Rate
  2.4.2 United States Biosimulation Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Biosimulation Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES BIOSIMULATION SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Biosimulation Sales and Market Share by Region (2012-2017)
3.2 United States Biosimulation Revenue and Market Share by Region (2012-2017)
3.3 United States Biosimulation Price by Region (2012-2017)

4 UNITED STATES BIOSIMULATION SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Biosimulation Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Biosimulation Revenue and Market Share by Type (2012-2017)
4.3 United States Biosimulation Price by Type (2012-2017)
4.4 United States Biosimulation Sales Growth Rate by Type (2012-2017)

5 UNITED STATES BIOSIMULATION SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Biosimulation Sales and Market Share by Application (2012-2017)
5.2 United States Biosimulation Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES BIOSIMULATION PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Accelrys
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Biosimulation Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Accelrys Biosimulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Certara
  6.2.2 Biosimulation Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Certara Biosimulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Simulation Plus
  6.3.2 Biosimulation Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Simulation Plus Biosimulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Dassault Systems SA
  6.4.2 Biosimulation Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Dassault Systems SA Biosimulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Schrodinger
  6.5.2 Biosimulation Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Schrodinger Biosimulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Advanced Chemistry Development
  6.6.2 Biosimulation Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Advanced Chemistry Development Biosimulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Chemical Computing Group
  6.7.2 Biosimulation Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Chemical Computing Group Biosimulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Entelos Holding Corporation
  6.8.2 Biosimulation Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Entelos Holding Corporation Biosimulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Genedata AG
  6.9.2 Biosimulation Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Genedata AG Biosimulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Physiomics PLC
  6.10.2 Biosimulation Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Physiomics PLC Biosimulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 BIOSIMULATION MANUFACTURING COST ANALYSIS

7.1 Biosimulation Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biosimulation

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Biosimulation Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biosimulation Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES BIOSIMULATION MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Biosimulation Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Biosimulation Sales Volume Forecast by Type (2017-2022)
11.3 United States Biosimulation Sales Volume Forecast by Application (2017-2022)
11.4 United States Biosimulation Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Biosimulation
Figure United States Biosimulation Market Size (Units) by Type (2012-2022)
Figure United States Biosimulation Sales Volume Market Share by Type (Product Category) in 2016
Figure Molecular Simulation Product Picture
Figure Clinical Trials Product Picture
Figure Toxicity Prediction Software Product Picture
Figure Other Product Picture
Figure United States Biosimulation Market Size (Units) by Application (2012-2022)
Figure United States Sales Market Share of Biosimulation by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Scientific Research Institutions Examples
Table Key Downstream Customer in Scientific Research Institutions
Figure Government Department Examples
Table Key Downstream Customer in Government Department
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Biosimulation Market Size (Million USD) by Region (2012-2022)
Figure The West Biosimulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Biosimulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Biosimulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Biosimulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Biosimulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Biosimulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Biosimulation Sales (Units) and Growth Rate (2012-2022)
Figure United States Biosimulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Biosimulation Market Major Players Product Sales Volume (Units) (2012-2017)
Table United States Biosimulation Sales (Units) of Key Players/Suppliers (2012-2017)
Table United States Biosimulation Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Biosimulation Sales Share by Players/Suppliers
Figure 2017 United States Biosimulation Sales Share by Players/Suppliers
Figure United States Biosimulation Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Biosimulation Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Biosimulation Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Biosimulation Revenue Share by Players/Suppliers
Figure 2017 United States Biosimulation Revenue Share by Players/Suppliers
Table United States Market Biosimulation Average Price (K USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Biosimulation Average Price (K USD/Unit) of Key Players/Suppliers in 2016
Figure United States Biosimulation Market Share of Top 3 Players/Suppliers
Figure United States Biosimulation Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Biosimulation Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Biosimulation Product Category
Table United States Biosimulation Sales (Units) by Region (2012-2017)
Table United States Biosimulation Sales Share by Region (2012-2017)
Figure United States Biosimulation Sales Share by Region (2012-2017)
Figure United States Biosimulation Sales Market Share by Region in 2016
Table United States Biosimulation Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Biosimulation Revenue Share by Region (2012-2017)
Figure United States Biosimulation Revenue Market Share by Region (2012-2017)
Figure United States Biosimulation Revenue Market Share by Region in 2016
Table United States Biosimulation Price (K USD/Unit) by Region (2012-2017)
Table United States Biosimulation Sales (Units) by Type (2012-2017)
Table United States Biosimulation Sales Share by Type (2012-2017)
Figure United States Biosimulation Sales Share by Type (2012-2017)
Figure United States Biosimulation Sales Market Share by Type in 2016
Table United States Biosimulation Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Biosimulation Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimulation by Type (2012-2017)
Figure Revenue Market Share of Biosimulation by Type in 2016
Table United States Biosimulation Price (K USD/Unit) by Types (2012-2017)
Figure United States Biosimulation Sales Growth Rate by Type (2012-2017)
Table United States Biosimulation Sales (Units) by Application (2012-2017)
Table United States Biosimulation Sales Market Share by Application (2012-2017)
Figure United States Biosimulation Sales Market Share by Application (2012-2017)
Figure United States Biosimulation Sales Market Share by Application in 2016
Table United States Biosimulation Sales Growth Rate by Application (2012-2017)
Figure United States Biosimulation Sales Growth Rate by Application (2012-2017)
Table Accelrys Basic Information List
Table Accelrys Biosimulation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Accelrys Biosimulation Sales Growth Rate (2012-2017)
Figure Accelrys Biosimulation Sales Market Share in United States (2012-2017)
Figure Accelrys Biosimulation Revenue Market Share in United States (2012-2017)
Table Certara Basic Information List
Table Certara Biosimulation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Certara Biosimulation Sales Growth Rate (2012-2017)
Figure Certara Biosimulation Sales Market Share in United States (2012-2017)
Figure Certara Biosimulation Revenue Market Share in United States (2012-2017)
Table Simulation Plus Basic Information List
Table Simulation Plus Biosimulation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Simulation Plus Biosimulation Sales Growth Rate (2012-2017)
Figure Simulation Plus Biosimulation Sales Market Share in United States (2012-2017)
Figure Simulation Plus Biosimulation Revenue Market Share in United States (2012-2017)
Table Dassault Systems SA Basic Information List
Table Dassault Systems SA Biosimulation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Dassault Systems SA Biosimulation Sales Growth Rate (2012-2017)
Figure Dassault Systems SA Biosimulation Sales Market Share in United States (2012-2017)
Figure Dassault Systems SA Biosimulation Revenue Market Share in United States (2012-2017)
Table Schrodinger Basic Information List
Table Schrodinger Biosimulation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Schrodinger Biosimulation Sales Growth Rate (2012-2017)
Figure Schrodinger Biosimulation Sales Market Share in United States (2012-2017)
Figure Schrodinger Biosimulation Revenue Market Share in United States (2012-2017)
Table Advanced Chemistry Development Basic Information List
Table Advanced Chemistry Development Biosimulation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Advanced Chemistry Development Biosimulation Sales Growth Rate (2012-2017)
Figure Advanced Chemistry Development Biosimulation Sales Market Share in United States (2012-2017)
Figure Advanced Chemistry Development Biosimulation Revenue Market Share in United States (2012-2017)
Table Chemical Computing Group Basic Information List
Table Chemical Computing Group Biosimulation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Chemical Computing Group Biosimulation Sales Growth Rate (2012-2017)
Figure Chemical Computing Group Biosimulation Sales Market Share in United States (2012-2017)
Figure Chemical Computing Group Biosimulation Revenue Market Share in United States (2012-2017)
Table Entelos Holding Corporation Basic Information List
Table Entelos Holding Corporation Biosimulation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Entelos Holding Corporation Biosimulation Sales Growth Rate (2012-2017)
Figure Entelos Holding Corporation Biosimulation Sales Market Share in United States (2012-2017)
Figure Entelos Holding Corporation Biosimulation Revenue Market Share in United States (2012-2017)
Table Genedata AG Basic Information List
Table Genedata AG Biosimulation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Genedata AG Biosimulation Sales Growth Rate (2012-2017)
Figure Genedata AG Biosimulation Sales Market Share in United States (2012-2017)
Figure Genedata AG Biosimulation Revenue Market Share in United States (2012-2017)
Table Physiomics PLC Basic Information List
Table Physiomics PLC Biosimulation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Physiomics PLC Biosimulation Sales Growth Rate (2012-2017)
Figure Physiomics PLC Biosimulation Sales Market Share in United States (2012-2017)
Figure Physiomics PLC Biosimulation Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimulation
Figure Manufacturing Process Analysis of Biosimulation
Figure Biosimulation Industrial Chain Analysis
Table Raw Materials Sources of Biosimulation Major Players/Suppliers in 2016
Table Major Buyers of Biosimulation
Table Distributors/Traders List
Figure United States Biosimulation Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Biosimulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Biosimulation Price (K USD/Unit) Trend Forecast (2017-2022)
Table United States Biosimulation Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Biosimulation Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Biosimulation Sales Volume (Units) Forecast by Type in 2022
Table United States Biosimulation Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Biosimulation Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Biosimulation Sales Volume (Units) Forecast by Application in 2022
Table United States Biosimulation Sales Volume (Units) Forecast by Region (2017-2022)
Table United States Biosimulation Sales Volume Share Forecast by Region (2017-2022)
Figure United States Biosimulation Sales Volume Share Forecast by Region (2017-2022)
Figure United States Biosimulation Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources